Those who qualify may receive*:
No health insurance or referral needed.
More than 37 million Americans have T2D. Around 80-90% of that number struggle to reach and stay at a healthy weight, and almost all have trouble controlling their blood sugar. All 3 of these health issues are among the most urgent facing people in the U.S. and around the world. We need more medication options.
Extra weight can lead to insulin resistance, which interferes with the transfer of sugar (glucose) out of your bloodstream. Persistently high blood sugar levels not only cause T2D, but increase your risk for T2D complications like heart, kidney, eye, and liver disease.
New therapies have been developed for T2D, but daily dosage schedules and administration can be challenging. This study is evaluating an investigational medication that will be administered subcutaneously just two times over the course of the study, with three months between injections.
If you’re 18 years old or older,
see if you qualify to join today.
Answer some questions
about your health
Tell us a little bit about yourself
Connect to available studies
in your area
AcurianHealth helps connect people with research studies that offer treatment under development.
Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.
©2024 Acurian, Inc. All rights reserved.
*In a research study, the participants may receive investigational study product or may receive an inactive substance, or placebo, depending on the study design. Participants receive study-related care from a doctor/research team for the duration of the study. The length of the study may vary.